VKIN yields 247.83% · JNJ yields 2.13%● Live data
📍 VKIN pulled ahead of the other in Year 1
Combined, VKIN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VKIN + JNJ for your $10,000?
Viking Energy Group, Inc., an exploration and production company, engages in the acquisition and development of oil and natural gas properties in North America. It manufactures and supplies power generation products, services, and custom energy solutions; clean-tech energy systems, including combined heat and power, tier 4 final diesel, and natural gas industrial engines, solar, wind, and storage; designs and assembles electrical control equipment, such as switch gear, synchronization and paralleling gear, distribution, Bi-fuel, and complete power generation production controls; and clean energy and carbon-capture systems to generate clean electricity. The company also engages in developing, patent pending, electric transmission, and distribution of open conductor detection systems to detect a break in a transmission line, distribution line, or coupling failure. The company owns oil and gas leases in Texas, Louisiana, Mississippi, and Kansas. The company was formerly known as Viking Investments Group, Inc. and changed its name to Viking Energy Group, Inc. in March 2017. Viking Energy Group, Inc. was incorporated in 1989 and is headquartered in Houston, Texas.
Full VKIN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.